Posted On: 10/26/2013 1:32:15 PM
Post# of 5326
TTNP Recent News
Drug stocks mixed; AstraZeneca gains on study 2:24 p.m. May 11, 2009 - Val Brickates Kennedy
Vanda, Titan rocket on drug approval 1:31 p.m. May 7, 2009 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 6:10 p.m. Dec. 2, 2008 - MarketWatch
Titan Pharmaceuticals to cut 40% of workforce 7:48 a.m. Dec. 2, 2008 - William L. Watts
Titan looking for partner or will divest Probuphine asset 7:36 a.m. Dec. 2, 2008 - Steve Goldstein
Titan Pharmaceuticals to cut 40% of its workforce 7:35 a.m. Dec. 2, 2008 - Steve Goldstein
Titan Pharmaceuticals up 3.2% at $2.28 9:48 a.m. March 16, 2007 - Tomi Kilgore
Titan Pharma receives $25 million in equity financing 8:06 a.m. March 16, 2007 - Tomi Kilgore
Titan Pharma receives $25M in equity financing from Azimuth 8:03 a.m. March 16, 2007 - Tomi Kilgore
Nasdaq pulls in to important support 11:53 a.m. Jan. 23, 2007 - Michael Ashbaugh
Nasdaq gets another test of notable support 11:20 a.m. Jan. 23, 2007 - Michael Ashbaugh
Highlights of rising and falling U.S. stocks 3:18 p.m. March 16, 2006 - Michael Baron
Titan Pharma up 4.5% at $1.85 9:37 a.m. Sept. 29, 2005 - Ciara Linnane
Titan Pharmaceuticals: Cornell to buy up to $35M in shares 7:19 a.m. Sept. 29, 2005 - Steve Goldstein
Titan Pharma: Cornell gets 5% fee on on each stock purchase 7:08 a.m. Sept. 29, 2005 - Robert Daniel
Titan Pharma: Per-share price based on 5-day weighted avg 7:07 a.m. Sept. 29, 2005 - Robert Daniel
Titan Pharma can access Cornell credit by issuing stock 7:06 a.m. Sept. 29, 2005 - Robert Daniel
Titan Pharma: Cornell to provide up to $35M funding 7:05 a.m. Sept. 29, 2005 - Robert Daniel
Titan Pharma gets equity line of credit from Cornell Capital 7:05 a.m. Sept. 29, 2005 - Robert Daniel
Titan Pharma Q2 R&D expense $4.5M vs. $5.7M 6:33 a.m. Aug. 9, 2004 - Tomi Kilgore
ILMN Seeks CE Mark For Upgraded Assay - Analyst Blog 6:48 p.m. Sept. 26, 2013 - Zacks.com
10-K/A: TITAN PHARMACEUTICALS INC 5:07 p.m. July 23, 2013 - Edgar Online - (EDG = 10Q, 10K)
PropThink Biotech Stocks to Buy with Big Gains: Cubist, Immunomedics and More 7:35 a.m. May 23, 2013 - 247WallSt.com
10-Q: TITAN PHARMACEUTICALS INC 4:44 p.m. May 15, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-K: TITAN PHARMACEUTICALS INC 6:20 a.m. March 18, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-Q: TITAN PHARMACEUTICALS INC 5:32 p.m. Nov. 9, 2012 - Edgar Online - (EDG = 10Q, 10K)
Titan Pharmaceuticals Announces Confirmation of Meeting With FDA Regarding Probuphine 4:52 p.m. Sept. 26, 2013 - Marketwire
Titan Pharmaceuticals Announces Submission of FDA Meeting Request Regarding Probuphine 7:01 a.m. Sept. 4, 2013 - Marketwire
Titan Pharmaceuticals Announces Second Quarter 2013 Financial Results 4:53 p.m. Aug. 14, 2013 - Marketwire
Titan Pharmaceuticals Announces Publication of Phase 3 Probuphine Data in Addiction 5:03 p.m. Aug. 13, 2013 - Marketwire
Titan Pharmaceuticals Schedules Conference Call to Review Second Quarter 2013 Financial Results 7:51 p.m. Aug. 8, 2013 - Marketwire
Titan Pharmaceuticals Announces Amendment to Partnership With Braeburn Pharmaceuticals 4:05 p.m. May 29, 2013 - Marketwire
Titan Pharmaceuticals Announces First Quarter 2013 Financial Results 8:30 p.m. May 15, 2013 - Marketwire
Titan Pharmaceuticals Schedules Conference Call to Review First Quarter 2013 Financial Results 8:01 a.m. May 9, 2013 - Marketwire
LOTE, OCTX and NDEV added to EPR's Active OTC Stock Watch List 11:14 a.m. May 7, 2013 - ACCESSWIRE-TNW
Titan Pharmaceuticals, Inc. and American Graphite Technologies Inc. Custom Reports Available on Stock Board 9:02 a.m. May 2, 2013 - ACCESSWIRE-TNW
Titan Pharmaceuticals Receives Complete Response Letter From the FDA for Probuphine New Drug Application 12:00 a.m. May 1, 2013 - Marketwire
Penny Stocks Trend Analysis Reports On: (OTCQB: TTNP), (OTCQX: KGFHY) 2:31 p.m. April 23, 2013 - ACCESSWIRE-TNW
GSR Adds OCTX, GOFF, SSOL to Active OTC Watch List 7:05 p.m. April 22, 2013 - ACCESSWIRE-TNW
OCTX, GOFF and SSOL added to EPR's Active OTC Watch List 10:48 a.m. April 22, 2013 - ACCESSWIRE-TNW
Titan Pharmaceuticals' Probuphine Program to Be Presented at ASAM Medical-Scientific Conference and APA Annual Meeting 7:01 a.m. April 22, 2013 - Marketwire
Futures Indicating Higher Open With Cyprus Deal in Sight - Volume Stock Trades Ahead of the Open: Goff Corp, Titan Pharmaceuticals, Fannie Mae, AMR Corp, Green Innovations 9:56 a.m. March 25, 2013 - PR Newswire
AMR Corporation News and Titan Pharmaceuticals Announcements: (OTCQB: AAMRQ), (OTCQB: TTNP) 1:37 a.m. March 25, 2013 - ACCESSWIRE-TNW
Volatility in Fannie Mae and Freddie Mac Brings Traders to the Front Lines - Top Small Cap Trades Ahead of the Open: Fannie Mae, AMR Corp, Goff Corp, Titan Pharmaceuticals, Research in Motion 8:10 a.m. March 22, 2013 - PR Newswire
Daily Trend Analysis Reports On: (OTCQB: TTNP), (OTCQB: AAMRQ) 3:20 a.m. March 22, 2013 - ACCESSWIRE-TNW
Titan Pharmaceuticals Announces FDA Advisory Committee Recommends Approval of Probuphine for the Treatment of Adult Patients With Opioid Dependence 7:32 p.m. March 21, 2013 - Marketwire
Drug stocks mixed; AstraZeneca gains on study 2:24 p.m. May 11, 2009 - Val Brickates Kennedy
Vanda, Titan rocket on drug approval 1:31 p.m. May 7, 2009 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 6:10 p.m. Dec. 2, 2008 - MarketWatch
Titan Pharmaceuticals to cut 40% of workforce 7:48 a.m. Dec. 2, 2008 - William L. Watts
Titan looking for partner or will divest Probuphine asset 7:36 a.m. Dec. 2, 2008 - Steve Goldstein
Titan Pharmaceuticals to cut 40% of its workforce 7:35 a.m. Dec. 2, 2008 - Steve Goldstein
Titan Pharmaceuticals up 3.2% at $2.28 9:48 a.m. March 16, 2007 - Tomi Kilgore
Titan Pharma receives $25 million in equity financing 8:06 a.m. March 16, 2007 - Tomi Kilgore
Titan Pharma receives $25M in equity financing from Azimuth 8:03 a.m. March 16, 2007 - Tomi Kilgore
Nasdaq pulls in to important support 11:53 a.m. Jan. 23, 2007 - Michael Ashbaugh
Nasdaq gets another test of notable support 11:20 a.m. Jan. 23, 2007 - Michael Ashbaugh
Highlights of rising and falling U.S. stocks 3:18 p.m. March 16, 2006 - Michael Baron
Titan Pharma up 4.5% at $1.85 9:37 a.m. Sept. 29, 2005 - Ciara Linnane
Titan Pharmaceuticals: Cornell to buy up to $35M in shares 7:19 a.m. Sept. 29, 2005 - Steve Goldstein
Titan Pharma: Cornell gets 5% fee on on each stock purchase 7:08 a.m. Sept. 29, 2005 - Robert Daniel
Titan Pharma: Per-share price based on 5-day weighted avg 7:07 a.m. Sept. 29, 2005 - Robert Daniel
Titan Pharma can access Cornell credit by issuing stock 7:06 a.m. Sept. 29, 2005 - Robert Daniel
Titan Pharma: Cornell to provide up to $35M funding 7:05 a.m. Sept. 29, 2005 - Robert Daniel
Titan Pharma gets equity line of credit from Cornell Capital 7:05 a.m. Sept. 29, 2005 - Robert Daniel
Titan Pharma Q2 R&D expense $4.5M vs. $5.7M 6:33 a.m. Aug. 9, 2004 - Tomi Kilgore
ILMN Seeks CE Mark For Upgraded Assay - Analyst Blog 6:48 p.m. Sept. 26, 2013 - Zacks.com
10-K/A: TITAN PHARMACEUTICALS INC 5:07 p.m. July 23, 2013 - Edgar Online - (EDG = 10Q, 10K)
PropThink Biotech Stocks to Buy with Big Gains: Cubist, Immunomedics and More 7:35 a.m. May 23, 2013 - 247WallSt.com
10-Q: TITAN PHARMACEUTICALS INC 4:44 p.m. May 15, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-K: TITAN PHARMACEUTICALS INC 6:20 a.m. March 18, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-Q: TITAN PHARMACEUTICALS INC 5:32 p.m. Nov. 9, 2012 - Edgar Online - (EDG = 10Q, 10K)
Titan Pharmaceuticals Announces Confirmation of Meeting With FDA Regarding Probuphine 4:52 p.m. Sept. 26, 2013 - Marketwire
Titan Pharmaceuticals Announces Submission of FDA Meeting Request Regarding Probuphine 7:01 a.m. Sept. 4, 2013 - Marketwire
Titan Pharmaceuticals Announces Second Quarter 2013 Financial Results 4:53 p.m. Aug. 14, 2013 - Marketwire
Titan Pharmaceuticals Announces Publication of Phase 3 Probuphine Data in Addiction 5:03 p.m. Aug. 13, 2013 - Marketwire
Titan Pharmaceuticals Schedules Conference Call to Review Second Quarter 2013 Financial Results 7:51 p.m. Aug. 8, 2013 - Marketwire
Titan Pharmaceuticals Announces Amendment to Partnership With Braeburn Pharmaceuticals 4:05 p.m. May 29, 2013 - Marketwire
Titan Pharmaceuticals Announces First Quarter 2013 Financial Results 8:30 p.m. May 15, 2013 - Marketwire
Titan Pharmaceuticals Schedules Conference Call to Review First Quarter 2013 Financial Results 8:01 a.m. May 9, 2013 - Marketwire
LOTE, OCTX and NDEV added to EPR's Active OTC Stock Watch List 11:14 a.m. May 7, 2013 - ACCESSWIRE-TNW
Titan Pharmaceuticals, Inc. and American Graphite Technologies Inc. Custom Reports Available on Stock Board 9:02 a.m. May 2, 2013 - ACCESSWIRE-TNW
Titan Pharmaceuticals Receives Complete Response Letter From the FDA for Probuphine New Drug Application 12:00 a.m. May 1, 2013 - Marketwire
Penny Stocks Trend Analysis Reports On: (OTCQB: TTNP), (OTCQX: KGFHY) 2:31 p.m. April 23, 2013 - ACCESSWIRE-TNW
GSR Adds OCTX, GOFF, SSOL to Active OTC Watch List 7:05 p.m. April 22, 2013 - ACCESSWIRE-TNW
OCTX, GOFF and SSOL added to EPR's Active OTC Watch List 10:48 a.m. April 22, 2013 - ACCESSWIRE-TNW
Titan Pharmaceuticals' Probuphine Program to Be Presented at ASAM Medical-Scientific Conference and APA Annual Meeting 7:01 a.m. April 22, 2013 - Marketwire
Futures Indicating Higher Open With Cyprus Deal in Sight - Volume Stock Trades Ahead of the Open: Goff Corp, Titan Pharmaceuticals, Fannie Mae, AMR Corp, Green Innovations 9:56 a.m. March 25, 2013 - PR Newswire
AMR Corporation News and Titan Pharmaceuticals Announcements: (OTCQB: AAMRQ), (OTCQB: TTNP) 1:37 a.m. March 25, 2013 - ACCESSWIRE-TNW
Volatility in Fannie Mae and Freddie Mac Brings Traders to the Front Lines - Top Small Cap Trades Ahead of the Open: Fannie Mae, AMR Corp, Goff Corp, Titan Pharmaceuticals, Research in Motion 8:10 a.m. March 22, 2013 - PR Newswire
Daily Trend Analysis Reports On: (OTCQB: TTNP), (OTCQB: AAMRQ) 3:20 a.m. March 22, 2013 - ACCESSWIRE-TNW
Titan Pharmaceuticals Announces FDA Advisory Committee Recommends Approval of Probuphine for the Treatment of Adult Patients With Opioid Dependence 7:32 p.m. March 21, 2013 - Marketwire
(0)
(0)Scroll down for more posts ▼
